Next Article in Journal
Roles of Copper-Binding Proteins in Breast Cancer
Next Article in Special Issue
Altered Adipogenesis in Zebrafish Larvae Following High Fat Diet and Chemical Exposure Is Visualised by Stimulated Raman Scattering Microscopy
Previous Article in Journal
Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction
Previous Article in Special Issue
Morphofunctional Alterations in Zebrafish (Danio rerio) Gills after Exposure to Mercury Chloride
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2017, 18(4), 864; doi:10.3390/ijms18040864

ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish

1
ZeClinics SL, PRBB (Barcelona Biomedical Research Park), 08003 Barcelona, Spain
2
Pivot Park Screening Centre (PPSC), Kloosterstraat 9, 5349AB OSS, The Netherland
3
Multilevel Dynamics in Morphogenesis Unit, USR3695 CNRS, 91190 Gif sur Yvette, France
These authors contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Academic Editor: Juliette Legler
Received: 1 March 2017 / Revised: 7 April 2017 / Accepted: 14 April 2017 / Published: 19 April 2017
(This article belongs to the Special Issue Zebrafish: A Model for Toxicological Research)
View Full-Text   |   Download PDF [4423 KB, uploaded 21 April 2017]   |  

Abstract

Toxicity is one of the major attrition causes during the drug development process. In that line, cardio-, neuro-, and hepatotoxicities are among the main reasons behind the retirement of drugs in clinical phases and post market withdrawal. Zebrafish exploitation in high-throughput drug screening is becoming an important tool to assess the toxicity and efficacy of novel drugs. This animal model has, from early developmental stages, fully functional organs from a physiological point of view. Thus, drug-induced organ-toxicity can be detected in larval stages, allowing a high predictive power on possible human drug-induced liabilities. Hence, zebrafish can bridge the gap between preclinical in vitro safety assays and rodent models in a fast and cost-effective manner. ZeGlobalTox is an innovative assay that sequentially integrates in vivo cardio-, neuro-, and hepatotoxicity assessment in the same animal, thus impacting strongly in the 3Rs principles. It Reduces, by up to a third, the number of animals required to assess toxicity in those organs. It Refines the drug toxicity evaluation through novel physiological parameters. Finally, it might allow the Replacement of classical species, such as rodents and larger mammals, thanks to its high predictivity (Specificity: 89%, Sensitivity: 68% and Accuracy: 78%). View Full-Text
Keywords: ZeGlobalTox; zebrafish; high-throughput; adverse drug reaction; drug toxicity; cardiotoxicity; neurotoxicity; hepatotoxicity ZeGlobalTox; zebrafish; high-throughput; adverse drug reaction; drug toxicity; cardiotoxicity; neurotoxicity; hepatotoxicity
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Cornet, C.; Calzolari, S.; Miñana-Prieto, R.; Dyballa, S.; van Doornmalen, E.; Rutjes, H.; Savy, T.; D’Amico, D.; Terriente, J. ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish. Int. J. Mol. Sci. 2017, 18, 864.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top